Refining hepatitis B screening and risk stratification in neuroinflammatory patients receiving immune therapy.

Yang F, Cheng J

Open source

DOI
10.1016/j.jfma.2026.09.026
Published
2026 Sep 19
Container
Journal of the Formosan Medical Association = Taiwan yi zhi
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jfma.2026.09.026,
  title = {Refining hepatitis B screening and risk stratification in neuroinflammatory patients receiving immune therapy.},
  author = {Yang F and Cheng J},
  year = {2026},
  journal = {Journal of the Formosan Medical Association = Taiwan yi zhi},
  doi = {10.1016/j.jfma.2026.09.026},
  url = {https://doi.org/10.1016/j.jfma.2026.09.026}
}

RIS

TY  - JOUR
TI  - Refining hepatitis B screening and risk stratification in neuroinflammatory patients receiving immune therapy.
AU  - Yang F
AU  - Cheng J
PY  - 2026
JO  - Journal of the Formosan Medical Association = Taiwan yi zhi
DO  - 10.1016/j.jfma.2026.09.026
UR  - https://doi.org/10.1016/j.jfma.2026.09.026
ER  - 

APA

F, Y., & J, C. (2026). Refining hepatitis B screening and risk stratification in neuroinflammatory patients receiving immune therapy.. Journal of the Formosan Medical Association = Taiwan yi zhi. https://doi.org/10.1016/j.jfma.2026.09.026

Source records